Xiayun Jin

发表

Prognostic Predictors Do Not Equate to Predictors of Chemotherapy Benefit in HR-Positive, HER2-Negative Breast Cancer: A Population-Based Study

Xifeng Xu, Jianfei Fu, L. Ling, 2020 .

Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer

Lunpo Wu, Xifeng Xu, Jianfei Fu, 2020, International Journal of Clinical Oncology.

Adverse Histological Features Alone Was Not Sufficient for Decision of Adjuvant Chemotherapy in T3N0M0 colonic cancer: A Propensity Score Matching Study Based on Population Analysis

Xifeng Xu, Jianfei Fu, Hongjuan Zheng, 2021 .

p.L105Vfs mutation in a family with thymic neuroendocrine tumor combined with MEN1: a case report

Ying Yuan, Jianfei Fu, Hongjuan Zheng, 2020, BMC Neurology.

Propofol Affects EGF's Activity in Intestinal Cell by Down-Regulating EGFR-Mediated Intracellular Signaling.

Duojia Xu, Wenyong Peng, Zhijian Lan, 2021, Biological and Pharmaceutical Bulletin.

Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study

Lihua Cao, Xiayun Jin, Xianfeng Li, 2017, World Journal of Surgical Oncology.

The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China

Xifeng Xu, Chenghui Li, Jianfei Fu, 2023, Scientific Reports.

The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups

Xifeng Xu, Jianfei Fu, Hongjuan Zheng, 2023, PloS one.

Resection of primary lesion with chemotherapy improves the survival of patients with metastatic colorectal neuroendocrine carcinoma.

Chenghui Li, R. Yin, Jianfei Fu, 2022, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences.

Netrin‑1 interference potentiates epithelial‑to‑mesenchymal transition through the PI3K/AKT pathway under the hypoxic microenvironment conditions of non‑small cell lung cancer.

Qi Wang, Lihua Cao, Lina Yan, 2019, International journal of oncology.

Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer.

Lunpo Wu, Xifeng Xu, jingjing zhu, 2021, Clinical breast cancer.

Higher Levels of Tumour-Infiltrating Lymphocytes (TILs) are Associated with a Better Prognosis, While CDK5 Plays a Different Role Between Nonmetastatic and Metastatic Colonic Carcinoma

R. Yin, B. Jiang, Jianfei Fu, 2023, Cancer control : journal of the Moffitt Cancer Center.

Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis

Wenxia Xu, Linchao Ding, Kailing Pan, 2023, BMC Medicine.

The Effect of Adjuvant Treatment in Small Node-negative HER2-positive Breast Cancer: Which Subgroup Will Benefit?

Xifeng Xu, Jianfei Fu, Hongjuan Zheng, 2020, Clinical breast cancer.

A Prediction Model for Chemotherapy-Induced Thrombocytopenia Based on Real-World Data and a Close Relationship Between AST/ALT Ratio and Platelet Count in Patients with Solid Tumors

Chenghui Li, Jianfei Fu, Hongjuan Zheng, 2022, International journal of general medicine.

Retrospective analysis of the impact of dose delay and reduction on outcomes of colorectal cancer patients treated with FOLFIRI‑based treatment

Hongjuan Zheng, Qinghua Wang, Xia Zhang, 2023, PeerJ.